Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

Chickenpox (Varicella Zoster Infection) Clinical Trials

A listing of Chickenpox (Varicella Zoster Infection) medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

RESULTS

Found (11) clinical trials

Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients

Safety and Tolerability of Herpes Zoster Vaccine in Patients with Rheumatoid Arthritis Immunized prior to biologics and tofacitinib therapy initiation Background The reactivation of varicella zoster virus (VZV) (herpes zoster (HZ)) is of substantial public health concern. Its predilection for the elderly and immunosuppressed make it an important cause of ...

Phase

Efficacy of Oral Famciclovir Versus Aciclovir Treatment in Patients With Herpes Zoster

Study Design single blind study, prospective, parallel group, intent to treat trial Experiment duration: 7 days 2 visits (days 0, and 7) Reduction of symptoms Adverse events evaluation

Phase

Safety and Immunogenicity of Measles Vaccine Varicella Vaccine and Hepatitis-A Vaccine

Measles vaccine (MV) can reduce childhood mortality and is currently recommended to all South African children aged 6 months. Only one study has examined the safety and immunogenicity of the recommended CAM-70 measles vaccine strain in children under 9 months of age. In addition, there are limited data on the ...

Phase

Efficacy Trial of a Vaccine to Prevent Herpes Zoster in Adults Over 40 Years of Age

Varicella-zoster virus (VZV) is a herpesvirus that causes two distinct clinical syndromes.Primary infection is manifested as varicella (chickenpox), whereas reactivation of latent VZV results in a localized eruption known as herpes zoster. More than 99.6% of people 40 years of age orolder had evidence of previous VZV infection. This study ...

Phase

Immunity Against Varicella in Pediatric Orthotopic Liver Transplantation Recipients

VZV vaccine given to pediatric liver transplant recipients at least one year after transplantation if tehy fulfill inclusion criteria and give informed consent.

Phase

Tzanck Smear With Methylene Blue Stain for Herpes

A smear from the lesional skin of the patients suspected having Herpes simplex, Herpes zoster and Varicella zoster skin infections will be collected (in a clinical routine setting). The specimen will be stained with methylene blue in addition to the Giemsa stain. Polymerase chain reaction study for herpes antigen will ...

Phase

Acupuncture in Herpes Zoster Neuralgia (ACUZoster)

Symptoms that herald herpes zoster include pruritus, dysesthesia and pain along the distribution of the involved dermatome. The most distressing symptom is typically pain and the most feared complication is postherpetic neuralgia (PHN), the persistence of pain long after rash healing. PHN is defined as pain persisting more than 3 ...

Phase

Optimal Timing of Zoster Vaccine After Hematopoietic Stem Cell Transplantation

Due to lack of data on safety of live vaccine in the recipient of hematopoietic stem cell transplantation, CIBMTR(Center for International Blood and Marrow Transplant Research) guidelines recommend varicella vaccination only in patients who is at least two years after transplantation and without graft versus host disease and no immunosuppressive ...

Phase N/A

A Comparative Study of FV-100 vs. Valacyclovir for the Prevention of Post-Herpetic Neuralgia

This is a multicenter, randomized, double-blind, parallel-group, active controlled comparative study of the safety and efficacy of 2 dosing regimens of FV-100 versus valacyclovir administered for 7 days in subjects with uncomplicated AHZ(acute herpes zoster). Subjects diagnosed with uncomplicated AHZ within 72 hours of lesion appearance and worst pain of ...

Phase

Evaluation of Immunogenicity and Safety of VARIVAX Passage Extension 34 (PE34) Process in Children (V210-A03)

This study will evaluate the immunogenicity, safety, and tolerability of VARIVAX (Varicella Virus Vaccine Live) manufactured with a new passage extension (PE34) process compared with the VARIVAX 2016 commercial process. The primary hypotheses being tested are that antibody response rate and mean antibody titer induced at 6 weeks after a ...

Phase